伊诺维奥制药

$伊诺维奥制药(INO)$ Janus Henderson集团股份有限公司已向美国证券交易委员会（SEC）提交了13G表格，披露其持有INOVIO Pharmaceuticals, Inc. 6.2%的股权。文件显示，Janus Henderson集团股份有限公司通过其间接子公司JHIUS、JHIUKL和JHIAIFML，实益拥有INOVIO普通股3,266,260股。这些股份是在正...

$伊诺维奥制药(INO)$ INOVIO完成滚动BLA提交，寻求加速批准INO-3107作为成人RRP的治疗方法（2025年11月3日）
复发性呼吸道乳头瘤病（RRP）是一种罕见的HPV相关呼吸道疾病，具有显著的未满足需求INO-3107之前获得了孤儿药物和突破性疗法的称号。
INOVIO根据FDA的加速批准计划提交了BLA，并...

$伊诺维奥制药(INO)$ Adage Capital Management, L.P.连同Robert Atchinson和Phillip Gross提交了13G表格，报告持有Inovio Pharmaceuticals, Inc. 9.99%的受益所有权。申报文件包含5,517,650股普通股和可行使认股权证的2,089,079股。这些股份由Adage Capital Partners, L.P.持有，并由Adage Capita...

$伊诺维奥制药(INO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000276  Act: 34  Size: 10 KB 网页链接

$伊诺维奥制药(INO)$ Alyeska投资集团有限合伙公司（Alyeska Investment Group, L.P.）连同Alyeska基金普通合伙人有限责任公司（Alyeska Fund GP, LLC）及Anand Parekh向美国证券交易委员会提交了13G表格，披露持有4,000,000股INOVIO PHARMACEUTICALS的A类普通股，占流通股的7.53%。文件表明这些股...

$伊诺维奥制药(INO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-004827  Act: 34  Size: 12 KB 网页链接

$伊诺维奥制药(INO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-005183  Act: 34  Size: 10 KB 网页链接

$伊诺维奥制药(INO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-004899  Act: 34  Size: 16 KB 网页链接

$伊诺维奥制药(INO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-25-275721  Act: 34  Size: 451 KB 网页链接

$伊诺维奥制药(INO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-275689  Act: 33  Size: 594 KB 网页链接

$伊诺维奥制药(INO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-274790  Act: 33  Size: 595 KB 网页链接

$伊诺维奥制药(INO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001055726-25-000063  Act: 34  Size: 8 MB 网页链接

$伊诺维奥制药(INO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000337  Act: 34  Size: 10 KB 网页链接

$伊诺维奥制药(INO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001055726-25-000064  Act: 34  Size: 305 KB 网页链接

$伊诺维奥制药(INO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-002964  Act: 34  Size: 11 KB 网页链接